191 related articles for article (PubMed ID: 3266971)
1. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
2. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G; Wiedmer E
Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
[No Abstract] [Full Text] [Related]
3. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
5. [Bactericidal activity "in vitro" of sulfamethoxazol-tri-methoprime (SMZ-TMP) alone and in combination with various antibiotics on bacterial strains isolated from urinary tract infections (author's transl)].
Joly B; Chanal M; Sirot D; Cluzel R; Jouan JP
Pathol Biol (Paris); 1979 Feb; 27(2):117-24. PubMed ID: 382045
[TBL] [Abstract][Full Text] [Related]
6. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
[TBL] [Abstract][Full Text] [Related]
7. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Gram-negative uropathogens isolated from obstetric patients.
Jamie WE; Edwards RK; Duff P
Infect Dis Obstet Gynecol; 2002; 10(3):123-6. PubMed ID: 12625967
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
Indiveri MC; Hirsh DC
J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
[TBL] [Abstract][Full Text] [Related]
10. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
11. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
Mengelers MJ; van Klingeren B; van Miert AS
Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Rawal BD; Cottis L
Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
[TBL] [Abstract][Full Text] [Related]
14. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.
Tosolini FA; Butcher RH
Clin Ther; 1983; 5(6):629-31. PubMed ID: 6605193
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.
Tartaglione TA; Johnson CR; Brust P; Opheim K; Hooton TM; Stamm WE
Antimicrob Agents Chemother; 1988 Nov; 32(11):1640-3. PubMed ID: 3075434
[TBL] [Abstract][Full Text] [Related]
17. [In vitro sensitivity (MIC) of Gram-negative bacilli exposed to the combination of trimethoprim-sulfamethopyrazine (Kelfiprim)].
Prado V; Aguirre X; Pinto ME; Soledad Giglio M
Rev Med Chil; 1982 Jan; 110(1):29-32. PubMed ID: 6818651
[No Abstract] [Full Text] [Related]
18. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
Legler F
Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
Gärtner H; Dieterich F
Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
[No Abstract] [Full Text] [Related]
20. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
